Ricciuti B - Search Results

1

Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.

Alessi JV, Price A, Richards AL, Ricciuti B, Wang X, Elkrief A, Pecci F, Di Federico A, Gandhi MM, Lebow ES, Santos PMG, Thor M, Rimner A, Schoenfeld AJ, Chaft JE, Johnson BE, Gomez DR, Awad MM, Shaverdian N. Alessi JV, et al. Among authors: ricciuti b. J Immunother Cancer. 2023 Nov;11(11):e007618. doi: 10.1136/jitc-2023-007618. J Immunother Cancer. 2023. PMID: 37914383 Free PMC article.

2

Double aortic arch with right positioned descending thoracic aorta and coexistent aortic kinking.

Ricciuti B, Rebonato A, Capodicasa E. Ricciuti B, et al. BMJ Case Rep. 2015 Dec 14;2015:bcr2015213270. doi: 10.1136/bcr-2015-213270. BMJ Case Rep. 2015. PMID: 26667664 Free PMC article. No abstract available.

3

Malignant giant solitary fibrous tumor of the pleura metastatic to the thyroid gland.

Ricciuti B, Metro G, Leonardi GC, Sordo RD, Colella R, Puma F, Ceccarelli S, Potenza R, Rebonato A, Maiettini D, Crinò L, Chiari R. Ricciuti B, et al. Tumori. 2016 Nov 11;102(Suppl. 2). doi: 10.5301/tj.5000514. Tumori. 2016. PMID: 27133228

4

Long-Lasting Response to Nivolumab and Immune-Related Adverse Events in a Nonsquamous Metastatic Non-Small Cell Lung Cancer Patient.

Ricciuti B, Metro G, Baglivo S, Colabrese D, Chiari R, Bennati C, Paglialunga L. Ricciuti B, et al. J Thorac Oncol. 2017 May;12(5):e51-e55. doi: 10.1016/j.jtho.2016.12.027. J Thorac Oncol. 2017. PMID: 28434516 Free article. No abstract available.

5

Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations.

Ricciuti B, Baglivo S, Ludovini V, Sidoni A, Metro G, Brambilla M, Siggillino A, Reda MS, Rebonato A, Maiettini D, Chiari R. Ricciuti B, et al. Lung Cancer. 2018 Jun;120:70-74. doi: 10.1016/j.lungcan.2018.04.002. Epub 2018 Apr 3. Lung Cancer. 2018. PMID: 29748019

6

Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?

De Giglio A, Porreca R, Brambilla M, Metro G, Prosperi E, Bellezza G, Pirro M, Chiari R, Ricciuti B. De Giglio A, et al. Among authors: ricciuti b. Thromb Res. 2018 Mar;163:51-53. doi: 10.1016/j.thromres.2017.12.004. Epub 2017 Dec 9. Thromb Res. 2018. PMID: 29353684 No abstract available.

7

Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy.

Ricciuti B, Foglietta J, Bianconi V, Sahebkar A, Pirro M. Ricciuti B, et al. Semin Cancer Biol. 2019 Jun;56:87-99. doi: 10.1016/j.semcancer.2017.11.005. Epub 2017 Nov 8. Semin Cancer Biol. 2019. PMID: 29128510 Review.

8

Targeting EGFR and ALK in NSCLC: current evidence and future perspective.

Bennati C, Paglialunga L, Ricciuti B, Metro G, Marcomigni L, Gili A, Crinò L. Bennati C, et al. Among authors: ricciuti b. Lung Cancer Manag. 2016 Jun;5(2):79-90. doi: 10.2217/lmt-2016-0005. Epub 2016 Jun 23. Lung Cancer Manag. 2016. PMID: 30643552 Free PMC article. Review.

9

Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications.

Ricciuti B, Foglietta J, Chiari R, Sahebkar A, Banach M, Bianconi V, Pirro M. Ricciuti B, et al. Med Oncol. 2017 Dec 4;35(1):4. doi: 10.1007/s12032-017-1064-5. Med Oncol. 2017. PMID: 29209837 Review.

10

Osimertinib.

Malapelle U, Ricciuti B, Baglivo S, Pepe F, Pisapia P, Anastasi P, Tazza M, Sidoni A, Liberati AM, Bellezza G, Chiari R, Metro G. Malapelle U, et al. Among authors: ricciuti b. Recent Results Cancer Res. 2018;211:257-276. doi: 10.1007/978-3-319-91442-8_18. Recent Results Cancer Res. 2018. PMID: 30069773 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page